AUPH - Aurinia Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5585.09M
Enterprise Value 3439.89M
Trailing P/E N/A
Forward P/E 1-11.56
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1,263.69
Price/Book (mrq)4.18
Enterprise Value/Revenue 3950.09
Enterprise Value/EBITDA 6-7.79

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-12,526.13%

Management Effectiveness

Return on Assets (ttm)-21.27%
Return on Equity (ttm)-41.86%

Income Statement

Revenue (ttm)463k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)-40.92M
EBITDA -56.45M
Net Income Avi to Common (ttm)-61.07M
Diluted EPS (ttm)-0.71
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)144.33M
Total Cash Per Share (mrq)1.57
Total Debt (mrq)421k
Total Debt/Equity (mrq)0.30
Current Ratio (mrq)23.31
Book Value Per Share (mrq)1.52

Cash Flow Statement

Operating Cash Flow (ttm)-50.38M
Levered Free Cash Flow (ttm)-31.59M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.03
52-Week Change 39.08%
S&P500 52-Week Change 36.11%
52 Week High 37.85
52 Week Low 35.06
50-Day Moving Average 36.37
200-Day Moving Average 36.45

Share Statistics

Avg Vol (3 month) 3557.05k
Avg Vol (10 day) 3451.8k
Shares Outstanding 585.34M
Float 66.77M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (May 31, 2019) 46.56M
Short Ratio (May 31, 2019) 414.5
Short % of Float (May 31, 2019) 4N/A
Short % of Shares Outstanding (May 31, 2019) 47.15%
Shares Short (prior month Apr 30, 2019) 46.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 250/1
Last Split Date 3Oct 23, 2013